BRIEF published on 04/04/2024 at 15:05, 1 year 10 months ago First Phase 2 Clinical Trial of Lassa Fever Vaccine Begins in Nigeria Phase 2 Clinical Trial Global Health Lassa Fever Vaccine IAVI CEPI
PRESS RELEASE published on 04/04/2024 at 15:00, 1 year 10 months ago Participants in Nigeria Vaccinated in First-Ever Phase 2 Lassa Fever Vaccine Clinical Trial, Sponsored by IAVI CEPI-funded study in Nigeria evaluates safety, tolerability, and immunogenicity of IAVI's Lassa fever vaccine candidate. First Phase 2 trial for any Lassa vaccine Phase 2 Trial IAVI CEPI Lassa Fever Vaccine Candidate
PRESS RELEASE published on 12/18/2023 at 15:00, 2 years 2 months ago IAVI and Zendal Announce Funding for Efficacy Trial of Promising TB Vaccine Candidate in Africa
PRESS RELEASE published on 07/07/2023 at 15:00, 2 years 7 months ago Germany Issues Award to IAVI to Support Development of the MTBVAC Tuberculosis Vaccine Candidate
PRESS RELEASE published on 06/27/2023 at 15:00, 2 years 7 months ago IAVI Starts First-in-Human Phase I Clinical Trial of Single-Dose Sudan Virus Vaccine Candidate
PRESS RELEASE published on 05/17/2023 at 15:00, 2 years 9 months ago Zendal and IAVI Announce Expanded Agreement to Partner on Development of TB Vaccine Candidate MTBVAC
PRESS RELEASE published on 03/02/2023 at 15:00, 2 years 11 months ago IAVI and BARDA Expand Partnership to Advance IAVI's Filovirus Vaccine Candidates
Published on 02/18/2026 at 15:15, 3 hours 31 minutes ago Host of "The Schaftlein Report" on Patriot.TV Delivers Urgent Warning to Trump: 2026 Midterm Course Correction Needed Now
Published on 02/18/2026 at 15:00, 3 hours 46 minutes ago Jaguar Health Announces a Special One-time Stock Dividend
Published on 02/18/2026 at 14:25, 4 hours 21 minutes ago Mako Mining Announces Amended and Restated Definitive Agreements for Restructure of Mt. Hamilton Acquisition Consideration and Filing of Supplement to Management Information Circular
Published on 02/18/2026 at 14:00, 4 hours 46 minutes ago Revolve Achieves Key Interconnection Milestone On 130 MW "El 24 Wind Project" In Mexico
Published on 02/18/2026 at 14:00, 4 hours 46 minutes ago Datametrex Receives $1M Order from Fortune 500 Client
Published on 02/18/2026 at 18:21, 24 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/18/2026 at 18:00, 46 minutes ago E-PANGO : Décision du Tribunal administratif de Paris en date du 16 février 2026
Published on 02/18/2026 at 17:58, 48 minutes ago 2CRSi SA: 2CRSi initiates, within the ÆTHER Infrastructure consortium, an exclusive negotiation for the establishment of a strategic industrial site dedicated to AI Gigafactories
Published on 02/18/2026 at 17:58, 48 minutes ago 2CRSi SA: 2CRSi initie, au sein du consortium ÆTHER Infrastructure, une négociation exclusive pour l’implantation d’un site industriel stratégique dédié aux AI Gigafactories
Published on 02/18/2026 at 15:50, 2 hours 56 minutes ago CGTN: Private economy: A key actor in advancing China's economic priorities in 2026 and beyond
Published on 02/18/2026 at 18:00, 46 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 janvier 2026
Published on 02/18/2026 at 18:00, 46 minutes ago Outstanding Shares and Voting Rights Statement at 31 January 2026
Published on 02/18/2026 at 13:45, 5 hours 1 minute ago NRJ GROUP - Non renouvellement Licence FM Nationale NRJ Suède
